首页> 中文期刊> 《现代肿瘤医学》 >HPIP与胰腺癌的相关性

HPIP与胰腺癌的相关性

         

摘要

Pancreatic carcinoma is one of the cancers with the worst prognosis,itˊs overall 5-year survival rate is below 5%,thus any therapeutic improvement is imperative. Hematopoietic Pbx-interaction protein( HPIP),is a novel scaffolding protein. Up to now,according to the relevant literature,HPIP is closely associated with tumor growth,prolif-eration and metastasis. HPIP may be a new target for cancer therapy in the future. In this paper,we will talk about whether there is a certain relevance between HPIP and pancreatic cancer.%胰腺癌是一种致死率极高的恶性肿瘤,总体五年生存率不及5%。就目前状况而言,胰腺癌的治疗方式有限、效果欠佳、前景堪忧,任何能够改善治疗的探索都是必要的。研究发现,雌激素受体( ER)在胰腺癌中广泛表达;HPIP是一种新型的支架蛋白。近年来相关文献已证实,HPIP与肿瘤细胞的增殖、转移密切相关,有可能成为肿瘤治疗的新靶点。本文就HPIP与胰腺癌的相关性进行初步探讨。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号